MusclePharm hires former ConAgra Foods veteran to head Operations

DENVER, March 3, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, today announced the appointment of Jon Heussner as its Vice President of Operations. 

Heussner has a proven track record as a seasoned supply chain executive, with experience in both business-to-business and business-to-consumer operations. He brings over 30 years of food manufacturing knowledge, focusing on operations management, engineering, contract manufacturing, new product commercialization, and project management.

"Jon will fit nicely into our improvement plan, helping reshape our supply chain operations. He is a veteran in supply chain and manufacturing, with a vast array of critical relationships that will bring tremendous value and cost savings to the company, creating efficiencies," said Ryan Drexler, MusclePharm Executive Chairman. "This hiring further enhances our capabilities in order to build a best-in-class supply chain and operations team."

Incoming Operations VP Jon Heussner added, "I'm truly excited to join the MusclePharm team and use my experience in operations and supply chain on our journey towards profitable growth and success."

Following is biographical information on Heussner:

Heussner has more than 30 years of operational and supply chain experience. He has held senior management positions at Hain Celestial Seasonings Group, ConAgra Foods, Tyson Foods, and Gilroy Foods & Spicetec. Heussner earned a B.S. from Miami University.

About MusclePharm Corporation
MusclePharm® is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements. The company offers a range of powders, capsules, tablets and gels. Its portfolio of recognized brands includes MusclePharm® Sport Series, Black Label and Core Series, Arnold Schwarzenegger Series™ and FitMiss™, which are available in more than 120 countries—over 45,000 retail outlets worldwide. The clinically-proven supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit http://www.musclepharm.com. To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts.

Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

Investors:
MusclePharm Investor Relations
303-396-6100
[email protected]

SOURCE MusclePharm Corporation